期刊
POLYHEDRON
卷 100, 期 -, 页码 264-270出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.poly.2015.08.034
关键词
Pt(II) complex; E. coli growth inhibition; Anticancer activity; In vivo; In vitro
资金
- Science and Technology Commission of Shanghai Municipality [13M1400200]
- Ministry of Science and Technology of the People's Republic of China [2013CB834501]
- National Natural Science Foundation of China [21102017]
- china postdoctoral association
Three trans-Pt(II) complexes, i.e. Pt(II)(salicylaldimine)(Py)Cl (C1), Pt(II)(salicyl-aldimine)(Py-4-carbinol) Cl (C2), and bi-metallic Pt(II)(2)(salicylaldimine)(Py)(2)Cl-2 (C3), have been synthesized and their structures have been characterized by NMR, HRMS and X-ray crystal analysis. Bioactivities, especially in vivo inhibition of Escherichia coil growth and in vitro cytotoxicity in MCF-7 and HepG2 human cancer cell lines have been investigated. The results disclosed that all three complexes have dominant retardation effects on E. coil growth and considerable cytotoxicity to both cancer cell lines, which were comparable to those of cisplatin. For E. coli growth inhibition, that of mono-metallic Cl was most prominent than those of polar side chain substituted C2 and bi-metallic C3. Cell cycle studies revealed that their abilities of blocking cell cycle progression in luminal like breast cancer cells caused inhibition of DNA synthesis. Keeping in view their convenient synthesis, stabilities and good cytotoxicities as well as their stronger retardation effects to cell growth in bacteria, this class of Pt(II) complexes could find a possible consideration in anticancer drug discovery. (C) 2015 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据